Phosphatidylserine Market

How big is Phosphatidylserine Market in 2026?

USD 196.7 Million in 2026 and USD 332.2 Million by 2036 at a 5.4% CAGR.

Sales of phosphatidylserine are estimated to grow at 5.4% from USD 196.7 Million in 2026 to USD 332.2 Million by 2036. The market was valued at USD 186.6 Million in 2025. Demand is concentrated in cognitive-health, stress-support, healthy-aging, and functional nutrition formulations where buyers need consistent potency and a source profile that fits the finished product. Powdered material remains commercially important because it works across capsules, sachets, premixes, and other concentrated formats.

The growth mechanism differs by country. Germany and several other European markets place strong emphasis on supplement notification and compliant health communication, while Canada's supplemented-food framework creates a defined route for soy phosphatidylserine under specified use conditions. US buyers operate in a mature supplement environment with established phosphatidylserine regulatory references. Commercial conversion therefore depends on aligning concentration, source, product format, labeling, and route-to-market requirements.

Key Takeaways

• Cognitive-health, stress-support, and healthy-aging formulations sustain ingredient demand across supplement and functional nutrition applications.
• Food Grade leads with a 53.9% share in 2026, supported by broad nutraceutical and food-compatible use.
• Powder accounts for 71.8% in 2026, reflecting its suitability for concentrated dry-dose formats and premixes.
• Conventional represents 89.2%, while Plant-based accounts for 69.3% of their respective categories.
• Germany records the highest profiled CAGR at 6.9%, followed by Canada at 6.6%.
• Chemi Nutra and IFF compete through branded phosphatidylserine ingredients, source options, formulation support, and format flexibility.

Analyst Perspective

Phosphatidylserine purchasing is moving beyond a generic ingredient specification. Formulators increasingly compare source identity, assay strength, physical format, and the documentation required for their target product. Suppliers that make these decisions easier can shorten formulation cycles and improve the likelihood of repeat orders.

- Nandini Roy Choudhury, Principal Consultant, Future Market Insights

How is the phosphatidylserine market segmented?

The phosphatidylserine market is segmented by Grade, Form, Nature, Source, and End Use.

Grade comprises Food Grade and Pharma Grade. Form includes Powder and Liquid. Nature is divided into Conventional and Organic. Source covers Plant-based and Animal-derived. End Use comprises Nutraceuticals, Food Industry, Cosmetics and Personal Care, and Pharmaceuticals. These applications place phosphatidylserine within the broader phospholipid market while creating different requirements for concentration, source documentation, processing behavior, and finished-product use.

Why does Food Grade lead demand within the Grade category?

Food Grade sits closest to the largest commercial routes for phosphatidylserine. Nutraceutical manufacturers and functional-food formulators can use standardized PS ingredients across multiple consumer wellness formats without the additional qualification requirements associated with pharmaceutical-grade material. Suppliers still need dependable purity and assay specifications, but the addressable customer base is broader.

• Food Grade holds 53.9% of Grade demand in 2026.
• Its lead reflects broad use across supplement, functional-food, and other food-compatible formulation routes.

Why does Powder lead demand within the Form category?

Powder offers concentration and handling advantages for capsules, sachets, tablets, and dry premixes. Formulators can achieve a defined phosphatidylserine dose without carrying the additional oil or carrier fraction associated with many liquid systems. Dry material also fits established supplement blending and encapsulation equipment.

• Powder accounts for 71.8% of Form demand in 2026.
• Concentrated dry material supports dose control, blending flexibility, storage, and high-throughput supplement production.

Why does Conventional lead demand within the Nature category?

Conventional phosphatidylserine benefits from established manufacturing routes and wider availability of standardized phospholipid feedstocks. Buyers can compare familiar assay ranges and specification packages across established commercial grades. Organic products require a narrower chain of qualifying feedstock and processing controls, reducing the pool of interchangeable supply.

• Conventional represents 89.2% of Nature demand in 2026.
• Broader feedstock availability and standardized industrial processing support routine commercial qualification.

Why does Plant-based lead demand within the Source category?

Plant-based phosphatidylserine aligns with the dominant food and nutraceutical routes in the market. Soy and sunflower inputs also allow formulators to avoid animal-origin material when building vegetarian or plant-oriented product propositions. The commercial advantage comes from source choice combined with recognizable ingredient specifications and scalable production.

• Plant-based accounts for 69.3% of Source demand in 2026.
• Soy and sunflower inputs support food, supplement, and wellness formulations that require non-animal sourcing.

Why do Nutraceuticals lead demand within the End Use category?

Nutraceuticals give manufacturers a straightforward way to deliver concentrated phosphatidylserine doses through capsules, powders, sachets, and combination formulas. These products also fit the commercial structure of the wider brain health supplement market, where formulation differentiation often comes from combining several cognitive or healthy-aging ingredients within one finished product.

• Nutraceuticals hold 58.1% of End Use demand in 2026.
• Concentrated serving formats and established cognitive-wellness positioning support a broad direct buyer base.

What are the drivers, restraints and opportunities in the Phosphatidylserine Market?

Cognitive-health formulation supports demand, qualification and claim controls slow commercialization, and plant-based format diversification creates new application opportunities.

• Cognitive-health, stress-support, and healthy-aging formulations generate recurring phosphatidylserine demand.
• Assay consistency, source documentation, labeling, and market-specific claims requirements can extend qualification.
• Plant-based powder and dispersible formats can widen use across supplements, functional foods, beverages, and beauty-from-within concepts.

The main growth driver is product development around cognition, focus, stress management, and healthy aging. Phosphatidylserine can be positioned as one ingredient within multi-component formulations rather than only as a standalone product. This fits the commercial structure of the wider dietary supplement market, where brands increasingly differentiate through ingredient combinations, dose formats, and consumer-specific propositions.

Qualification remains the main source of friction. A supplier must deliver consistent phosphatidylserine concentration while supporting the declared source and intended product format. Food and supplement manufacturers also need finished-product communication that fits the rules in their target country. Pharmaceutical buyers add another layer through tighter quality, impurity, and formulation requirements. These conditions increase the value of suppliers that can provide repeatable specifications instead of competing only on ingredient price.

Source and format diversification create the clearest growth opportunity. Powder continues to dominate, but dispersible systems can widen access to the functional foods market and beverage concepts where a conventional dry capsule proposition is less suitable. Soy and sunflower options also give formulators more flexibility when responding to consumer preferences around plant-derived ingredients.

Pharma Grade remains a smaller but more specification-intensive opportunity. Buyers serving the pharmaceutical lipids market are more likely to evaluate assay consistency, batch documentation, process suitability, and supplier quality systems before changing grades. This creates room for higher-value material where technical support reduces formulation and qualification work.

Which country CAGRs are profiled in the Phosphatidylserine Market?

Country	CAGR
Germany	6.9%
Canada	6.6%
UK	6.2%
USA	5.8%
France	5.5%
Australia	5.2%
Poland	4.9%
Italy	4.5%

How do country-level CAGRs compare in the Phosphatidylserine Market?

Germany records the fastest profiled growth at 6.9%, followed by Canada at 6.6% and the UK at 6.2%. The USA is forecast at 5.8%, France at 5.5%, Australia at 5.2%, Poland at 4.9%, and Italy at 4.5%. Differences in notification systems, health-claim rules, supplemented-food pathways, and supplement regulation shape how quickly formulation interest can convert into commercial sales.

• Supplement notification and clear food-versus-medicine positioning make technical documentation important for market entry.
• A defined supplemented-food pathway for soy phosphatidylserine supports additional formats under specified use and labeling conditions.
• Commercial health communication must align with the Great Britain nutrition and health claims register.
• A mature supplement environment places greater emphasis on source, potency, formulation support, and differentiated branded ingredients.
• Active supplement enforcement increases the importance of conservative claims and accurate product composition.
• Complementary-medicine pathways increase the importance of ingredient suitability and sponsor documentation.
• Supplements remain regulated as foods, making treatment-oriented positioning unsuitable for normal supplement commercialization.
• Notification and register inclusion place continuing compliance responsibility on the operator marketing the product.

Country-wise Analysis

• Germany: Germany is expected to grow at a CAGR of 6.9% from 2026 to 2036. Supplement manufacturers operate with a formal notification route under the country's Nahrungsergänzungsmittel framework. This places practical value on ingredient files that can be transferred efficiently into finished-product notifications and labels. Phosphatidylserine suppliers offering clear source, assay, and specification information can reduce administrative work for customers developing cognitive-health or healthy-aging formulations.
• Canada: Canada is projected to expand at a CAGR of 6.6% from 2026 to 2036. The country's current supplemented-food framework permits phosphatidylserine made from food-grade soy lecithin under defined conditions, including a maximum daily amount and adult-use cautions. This creates a practical commercial route beyond conventional capsules while keeping dose and labeling discipline central to formulation decisions. Suppliers that combine soy-source traceability with consistent potency are better positioned to serve food and wellness brands.
• UK: The UK is forecast to grow at a CAGR of 6.2% from 2026 to 2036. Great Britain's nutrition and health claims register was updated in May 2026 and remains the central reference for claims used in commercial food communications. Cognitive and memory positioning therefore requires careful wording. Ingredient suppliers can add value by giving brand owners precise formulation information that supports legal and marketing review without turning an ingredient proposition into an unauthorized therapeutic claim.
• USA: The USA is expected to grow at a CAGR of 5.8% from 2026 to 2036. The market benefits from established consumer familiarity with brain-health supplements and a mature branded-ingredient channel. FDA's current dietary supplement ingredient information continues to reference phosphatidylserine within its qualified-health-claim framework. This shifts competition toward branded differentiation, concentration, source options, formulation performance, and supply reliability rather than basic category awareness.
• France: France is projected to record a CAGR of 5.5% from 2026 to 2036. In November 2025, DGCCRF reported supplement-control findings covering therapeutic claims, unjustified claims, and composition issues. The enforcement environment increases the commercial value of disciplined ingredient documentation. Suppliers supporting French brand owners need to keep technical specifications separate from disease-treatment language while providing enough information for formulation, label, and quality review.
• Australia: Australia is expected to grow at a CAGR of 5.2% from 2026 to 2036. TGA updates during 2025 reinforced the country's structured approach to permissible ingredients and complementary medicines. Sponsors remain responsible for matching ingredients and indications to the appropriate regulatory pathway. Phosphatidylserine suppliers can therefore compete through specification quality, source clarity, and technical packages that help customers assess suitability before product launch.
• Poland: Poland is forecast to grow at a CAGR of 4.9% from 2026 to 2036. In September 2025, the Chief Sanitary Inspectorate reiterated that dietary supplements are foods rather than medicines and cannot be promoted as treatments. This distinction matters for phosphatidylserine because cognitive positioning can move easily into medical language. Clear composition records and restrained commercial claims help manufacturers build products that remain within the food-supplement route.
• Italy: Italy is projected to grow at a CAGR of 4.5% from 2026 to 2036. The Ministry of Health updated its supplement register in July 2026 and states that successful notification and register inclusion do not transfer compliance responsibility away from the food business operator. Established phosphatidylserine grades can therefore benefit from strong supporting documentation that simplifies notification, labeling, and ongoing product-control work.

Who are the notable companies in the Phosphatidylserine Market?

Chemi Nutra and IFF are the notable direct phosphatidylserine ingredient companies profiled in this market.

Competition is concentrated around branded phosphatidylserine ingredients that give formulators a defined source, standardized assay, usable physical format, and application support. Chemi Nutra markets SerinAid across supplement and functional-food applications. IFF participates through its Sharp-PS portfolio, which covers multiple concentrations, physical formats, sources, and wellness applications.

• Chemi Nutra competes through the SerinAid branded platform and formulation support across powders, capsules, functional foods, and ready-to-drink applications.
• IFF competes through Sharp-PS, including multiple phosphatidylserine concentrations and powder, fine-powder, and dispersion formats.

Competitive Benchmarking: Phosphatidylserine Market

Company	Direct PS Ingredient Portfolio	Source and Format Flexibility	End-use Formulation Coverage	Geographic Reach
Chemi Nutra	High	Medium	High	United States base with international formulation support
IFF	High	High	High	International health-sciences channels

High indicates broad capability within the stated benchmark. Medium indicates a narrower but established position. The benchmark compares ingredient and formulation capabilities and does not represent company market share.

Key Developments in the Phosphatidylserine Market

• In May 2026, Great Britain's nutrition and health claims register was updated, reinforcing the need for food and supplement brands to use authorized commercial health claims.
• In July 2026, Italy updated its national supplement register, maintaining a notification-led route in which responsibility for product compliance remains with the operator placing the supplement on the market.
• In November 2025, France's DGCCRF reported continued supplement-control issues involving therapeutic claims, unjustified claims, and composition, increasing the value of disciplined technical and labeling support.
• In September 2025, Poland's Chief Sanitary Inspectorate reiterated that dietary supplements are foods and cannot be presented as products that treat disease.

Key Players in the Phosphatidylserine Market

Branded Phosphatidylserine Ingredient Specialists

• Chemi Nutra
• IFF

Phosphatidylserine Market - Report Scope

Coverage field	Report scope
Market breakdown	Grade; Form; Nature; Source; End Use; Region
Quantitative Units	USD Million
Market Definition	Revenue from phosphatidylserine sold as Food Grade or Pharma Grade ingredient material in Powder or Liquid form across Conventional or Organic and Plant-based or Animal-derived sources for the stated end uses. Downstream finished supplements, foods, cosmetics, pharmaceuticals, services, and substitute products are excluded.
Regions Covered	North America; Latin America; Western Europe; Eastern Europe; East Asia; South Asia and Pacific; Middle East and Africa
Countries Covered	USA; Canada; Germany; France; UK; Australia; Italy; Poland
Key Companies Profiled	Chemi Nutra; IFF
Forecast Period	2026 to 2036
Approach	Primary and secondary research with market triangulation

Phosphatidylserine Market - Research Methodology

Method	Approach
Primary Research	FMI analysts gathered input from ingredient manufacturers, distributors, product developers, procurement teams, end users, and subject-matter experts. Discussions examined formulation requirements, purchasing criteria, qualification, price, technical support, and supply continuity.
Desk Research	Research covered government publications, regulatory material, technical literature, standards, company information, product specifications, and official announcements.
Market Sizing and Forecasting	Market sizing considers the baseline value, segment structure, pricing and volume indicators, formulation adoption, company participation, and country-level demand conditions. Forecast assumptions incorporate regulatory developments, consumer wellness trends, qualification cycles, source preference, and product-format innovation.
Data Validation	Estimates are compared across segment demand, regulatory activity, company participation, product applications, and country conditions to maintain consistent market boundaries.

Phosphatidylserine Market by Segments

Phosphatidylserine Market segmented by Grade:

• Food Grade
• Pharma Grade

Phosphatidylserine Market segmented by Form:

• Powder
• Liquid

Phosphatidylserine Market segmented by Nature:

• Conventional
• Organic

Phosphatidylserine Market segmented by Source:

• Plant-based
• Animal-derived

Phosphatidylserine Market segmented by End Use:

• Nutraceuticals
• Food Industry
• Cosmetics and Personal Care
• Pharmaceuticals

Phosphatidylserine Market by Region:

• North America
  • United States
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
• Western Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Benelux
  • Nordics
• Eastern Europe
  • Poland
  • Czech Republic
  • Romania
  • Hungary
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia and New Zealand
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Türkiye
  • Israel

Research Sources and Bibliography

• U.S. Food and Drug Administration (2026). Information on Select Dietary Supplement Ingredients and Other Substances.
• Health Canada (2026). List of Permitted Supplemental Ingredients.
• Department of Health and Social Care (2026, May 19). Great Britain Nutrition and Health Claims Register.
• Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (2025). Anzeigeformular § 5 NemV.
• Direction générale de la concurrence, de la consommation et de la répression des fraudes (2025, November 3). Compléments alimentaires: des anomalies encore trop nombreuses.
• Therapeutic Goods Administration (2025). Updates to Listed Medicine Ingredients.
• Główny Inspektorat Sanitarny (2025, September 30). Suplementy diety to nie leki.
• Ministero della Salute (2026, July 3). Registro degli integratori alimentari.
• Chemi Nutra. SerinAid Phosphatidylserine Ingredient Profile.
• IFF Health Sciences. Sharp-PS Brain Health.
• IFF Health Sciences. Sharp-PS Beauty.

This Report Answers

• How large is the Phosphatidylserine Market in 2025 and 2026, and what value is forecast for 2036?
• What is the market CAGR from 2026 to 2036?
• Why does Food Grade lead demand within the Grade category?
• Why does Powder dominate the Form category?
• Why do Conventional and Plant-based products lead their respective categories?
• Why are Nutraceuticals the largest End Use?
• How do country growth rates differ across the eight profiled markets?
• Which current direct ingredient companies compete through branded phosphatidylserine products?